Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Operating Income
Burning Rock Biotech Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Operating Income
¥-980.4m
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
¥-12B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
¥-3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥5.5B
|
CAGR 3-Years
201%
|
CAGR 5-Years
99%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥9.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
46%
|
CAGR 10-Years
47%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Income
¥1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Operating Income?
Operating Income
-980.4m
CNY
Based on the financial report for Dec 31, 2022, Burning Rock Biotech Ltd's Operating Income amounts to -980.4m CNY.
What is Burning Rock Biotech Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-52%
Over the last year, the Operating Income growth was -23%. The average annual Operating Income growth rates for Burning Rock Biotech Ltd have been -80% over the past three years , -52% over the past five years .